Palliation of advanced gastrointestinal malignancies using minimally invasive strategies

Progress in Palliative Care

Volumn 17, Issue 5, 2009, Pages 250-260

  Augustine, Mathew M ^a   Pawlik, Timothy M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Colorectal cancer; Minimally invasive; Neuroendocrine tumors; Palliative care; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; SOMATOSTATIN;

ADVANCED CANCER; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHOLECYSTECTOMY; CHRONIC PAIN; CLINICAL TRIAL; COLON CANCER; COLON OBSTRUCTION; COLON RESECTION; COLORECTAL CANCER; COLOSTOMY; COMPUTER ASSISTED SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DECOMPRESSION SURGERY; DIGESTIVE SYSTEM CANCER; EMERGENCY SURGERY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; FLUOROSCOPY; GASTROJEJUNOSTOMY; HEALTH CARE NEED; HUMAN; INSULINOMA; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; LAPAROSCOPIC SURGERY; LOW LEVEL LASER THERAPY; MINIMALLY INVASIVE SURGERY; NEODYMIUM LASER; NEUROENDOCRINE TUMOR; NON INVASIVE PROCEDURE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATICODUODENECTOMY; PATIENT SAFETY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; RISK REDUCTION; SOCIAL ASPECT; SPIRITUAL CARE; STOMACH OBSTRUCTION; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; UNSPECIFIED SIDE EFFECT;

EID: 70350192139     PISSN: 09699260     EISSN: 1743291X     Source Type: Journal    
DOI: 10.1179/096992609X12455871937260     Document Type: Review

References (64)

1. Winter JM, Cameron JL, Campbell KA et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a singleinstitution experience. J Gastrointest Surg 2006; 10: 1199-1210, discussion 1210-1211.
2. Sitzmann JV, Greene PS. Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 1994; 219: 13-17.
3. Miner TJ, Brennan MF, Jaques DP. A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg 2004; 240: 719-726, discussion 726-727.
4. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
5. McGregor JR, O'Dwyer PJ. The surgical management of obstruction and perforation of the left colon. Surg Gynecol Obstet 1993; 177: 203-208.
6. Serpell JW, McDermott FT, Katrivessis H, Hughes ES. Obstructing carcinomas of the colon. Br J Surg 1989; 76: 965-969.
7. Griffin MR, Bergstralh EJ, Coffey RJ et al. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987; 60: 2318-2324.
8. Scoggins CR, Meszoely IM, Blanke CD et al. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999; 6: 651-657.
9. Scheer MG, Sloots CE, van der Wilt GJ, Ruers TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008; 19: 1829-1835.
10. Joffe J, Gordon PH. Palliative resection for colorectal carcinoma. Dis Colon Rectum 1981; 24: 355-360.
11. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004; 350: 2050-2059.
12. Guillou PJ, Quirke P, Thorpe H et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365: 1718-1726.
13. Lacy AM, Garcia-Valdecasas JC, Delgado S et al. Laparoscopyassisted colectomy versus open colectomy for treatment of nonmetastatic colon cancer: a randomised trial. Lancet 2002; 359: 2224-2229.
14. Veldkamp R, Kuhry E, Hop WC et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 2005; 6: 477-484.
15. Jayne DG, Guillou PJ, Thorpe H et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007; 25: 3061-3068.
16. Weeks JC, Nelson H, Gelber S et al. Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA 2002; 287: 321-328.
17. Yang L, Yu YY, Zhou ZG et al. Quality of life outcomes following laparoscopic total mesorectal excision for low rectal cancers: a clinical control study. Eur J Surg Oncol 2007; 33: 575-579.
18. Ludwig KA, Milsom JW, Garcia-Ruiz A, Fazio VW. Laparoscopic techniques for fecal diversion. Dis Colon Rectum 1996; 39: 285-288.
19. Dohomoto M. New method: endoscopic implantation of rectal stent in palliative treatment of malignant stenosis. Endosc Dig 1991; 3: 1507-1512.
20. Law WL, Choi HK, Chu KW. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br J Surg 2003; 90: 1429-1433.
21. Martinez-Santos C, Lobato RF, Fradejas JM et al. Self-expandable stent before elective surgery vs. emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates. Dis Colon Rectum 2002; 45: 401-406.
22. Watt AM, Faragher IG, Griffin TT et al. Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg 2007; 246: 24-30.
23. Balague C, Targarona EM, Sainz S et al. Minimally invasive treatment for obstructive tumors of the left colon: endoluminal selfexpanding metal stent and laparoscopic colectomy. Preliminary results. Dig Surg 2004; 21: 282-286.
24. Morino M, Bertello A, Garbarini A et al. Malignant colonic obstruction managed by endoscopic stent decompression followed by laparoscopic resections. Surg Endosc 2002; 16: 1483-1487.
25. Stipa F, Pigazzi A, Bascone B et al. Management of obstructive colorectal cancer with endoscopic stenting followed by single-stage surgery: open or laparoscopic resection? Surg Endosc 2008; 22: 1477-1481.
26. Vandervoort J, Tham TC. Colonic stents for malignant obstruction-not a bridge too far? Gastrointest Endosc 2006; 64: 921-924.
27. Eckhauser ML, Mansour EG. Endoscopic laser therapy for obstructing and/or bleeding colorectal carcinoma. Am Surg 1992; 58: 358-363.
28. Gevers AM, Macken E, Hiele M, Rutgeerts P. Endoscopic laser therapy for palliation of patients with distal colorectal carcinoma: analysis of factors influencing long-term outcome. Gastrointest Endosc 2000; 51: 580-585.
29. Xinopoulos D, Dimitroulopoulos D, Tsamakidis K et al. Treatment of malignant colonic obstructions with metal stents and laser. Hepatogastroenterology 2002; 49: 359-362.
30. Kimmey MB. Endoscopic methods (other than stents) for palliation of rectal carcinoma. J Gastrointest Surg 2004; 8: 270-273.
31. Lillemoe KD, Cameron JL, Kaufman HS et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993; 217: 447-455, discussion 456-457.
32. Kokoska ER, Stapleton DR, Virgo KS et al. Quality of life measurements do not support palliative pancreatic cancer treatments. Int J Oncol 1998; 13: 1323-1329.
33. Huang JJ, Yeo CJ, Sohn TA et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 2000; 231: 890-898.
34. Sohn TA, Lillemoe KD, Cameron JL et al. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg 1999; 188: 658-666, discussion 666-669.
35. Lillemoe KD, Cameron JL, Hardacre JM et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999; 230: 322-328, discussion 328-330.
36. Van Heek NT, De Castro SM, van Eijck CH et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 2003; 238: 894-902, discussion 902-905.
37. Tilleman EH, Busch OR, Bemelman WA et al. Diagnostic laparoscopy in staging pancreatic carcinoma: developments during the past decade. J Hepatobiliary Pancreat Surg 2004; 11: 11-16.
38. Espat NJ, Brennan MF, Conlon KC. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg 1999; 188: 649-655, discussion 655-657.
39. Smith AC, Dowsett JF, Russell RC et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 344: 1655-1660.
40. Artifon EL, Sakai P, Cunha JE et al. Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol 2006; 101: 2031-2037.
41. Speer AG, Cotton PB, Russell RC et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987; 2: 57-62.
42. Date RS, Siriwardena AK. Current status of laparoscopic biliary bypass in the management of non-resectable peri-ampullary cancer. Pancreatology 2005; 5: 325-329.
43. Wong YT, Brams DM, Munson L et al. Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation. Surg Endosc 2002; 16: 310-312.
44. Nassif T, Prat F, Meduri B et al. Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study. Endoscopy 2003; 35: 483-489.
45. Rhodes M, Nathanson L, Fielding G. Laparoscopic biliary and gastric bypass: a useful adjunct in the treatment of carcinoma of the pancreas. Gut 1995; 36: 778-780.
46. Kazanjian KK, Reber HA, Hines OJ. Laparoscopic gastrojejunostomy for gastric outlet obstruction in pancreatic cancer. Am Surg 2004; 70: 910-913.
47. Alter CL. Palliative and supportive care of patients with pancreatic cancer. Semin Oncol 1996; 23: 229-240.
48. Kelsen DP, Portenoy R, Thaler H et al. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997; 122: 53-59.
49. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995; 80: 290-295.
50. Wong GY, Schroeder DR, Carns PE et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004; 291: 1092-1099.
51. Pietrabissa A, Vistoli F, Carobbi A et al. Thoracoscopic splanchnicectomy for pain relief in unresectable pancreatic cancer. Arch Surg 2000; 135: 332-335.
52. Gress F, Schmitt C, Sherman S et al. A prospective randomized comparison of endoscopic ultrasound-and computed tomographyguided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol 1999; 94: 900-905.
53. Strong VE, Dalal KM, Malhotra VT et al. Initial report of laparoscopic celiac plexus block for pain relief in patients with unresectable pancreatic cancer. J Am Coll Surg 2006; 203: 129-131.
54. Sarmiento JM, Heywood G, Rubin J et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197: 29-37.
55. Curley SA, Izzo F, Abdalla E, Vauthey JN. Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev 2004; 23: 165-182.
56. Mazzaglia PJ, Berber E, Milas M, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 2007; 142: 10-19.
57. Sebastian S, Johnston S, Geoghegan T et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004; 99: 2051-2057.
58. Brunetaud JM, Maunoury V, Cochelard D. Lasers in rectosigmoid tumors. Semin Surg Oncol 1995; 11: 319-327.
59. Milsom JW, Kim SH, Hammerhofer KA, Fazio VW. Laparoscopic colorectal cancer surgery for palliation. Dis Colon Rectum 2000; 43: 1512-1516.
60. Ho AS, Picus J, Darcy MD et al. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol 2007; 188: 1201-1207.
61. Strosberg JR, Choi J, Cantor AB, Kvols LK. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control 2006; 13: 72-78.
62. Gupta S, Johnson MM, Murthy R et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 2005; 104: 1590-1602.
63. Roche A, Girish BV, de Baere T et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003; 13: 136-140.
64. Chamberlain RS, Canes D, Brown KT et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000; 190: 432-445.